Aastrom Biosciences, Inc. reports on the results of Phase I/II clinical trials of the TRC [Tissue Repair Cells] product in patients with bone fractures

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Full Text

Restricted Access

About the authors

A. V. Volkov

Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation

A. V. Bersenev

Email: redaktor@celltranspl.ru
Russian Federation


  1. Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities. 2005, MedMarket Diligense, LLC.

Copyright (c) 2006 Eco-Vector

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 57156 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies